Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia

Official title: Clinical Performance Evaluation of Two Monthly Replacement Silicone Hydrogel Multifocal Toric Lens Designs in Habitual Soft Contact Lens Wearers

Run by CooperVision International Limited (CVIL) · NCT07829419 · Data updated 2026-11-12

This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.

More Myopia trials

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment60 (estimated)
SponsorCooperVision International Limited (CVIL)
Industry-sponsored
Locations3 sites (New York, New York and 2 other locations)
StatusRecruiting
StartedNovember 2, 2026
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedNovember 4, 2026
Trial IDNCT07829419 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 40+ with myopia up to -6.00 D, astigmatism 0.75–2.00 D, plano to -6.00 D spherical refractive error, reading add of +0.75 D or more, and a habit of wearing soft multifocal toric lenses.

Probably not a fit

Patients outside the refractive error range, with higher astigmatism, or with insufficient wear history may not benefit from these lenses.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, subject-masked, bilateral crossover study comparing Lens A (comfilcon A) and Lens B (lehfilcon A) in soft contact lens wearers. Eligible participants are 40 years or older with myopia up to -6.00 diopters, astigmatism 0.75 to 2.00 diopters, and a reading add of at least +0.75 diopters. Each participant will wear both lenses in a randomized sequence, allowing direct comparison of performance. The study collects outcomes such as visual acuity and comfort to determine relative performance.

Why it matters

Potential benefit: If successful, the better-performing lens could offer improved vision quality and comfort for people with astigmatism and myopia.

How similar studies have gone: Previous studies have explored multifocal toric lenses, but this specific bilateral crossover comparison of two silicone hydrogel lenses is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

A person is eligible for inclusion in the study if they are:

1. Participants at least 40 years of age.
2. Participants requiring lens powers within the range available for the study lenses.
3. Participants with a spherical refractive error at the corneal plane of plano to -6.00.
4. Participants with a minimum reading add of +0.75DS (based on their spectacle refraction at screening). At least 12 participants will be enrolled per add group: low (+0.75 to +1.25D), medium (+1.50 to +1.75D), and high (+2.00 to +2.50).
5. Participants with refractive astigmatism at the corneal plane of 0.75 to 2.00DC.
6. Best spectacle corrected visual acuity greater than or equal to 20/25 (less than or equal to LogMAR 0.1).
7. Habitually using soft contact lenses (multifocal soft contact lenses, sphere or toric lenses for monovision, or sphere or toric lenses for distance vision correction and spectacles for near vision correction) and have worn lenses at least 3 days a week for at least the past six months.
8. Anticipating being able to wear contact lenses for at least 8 hours a day, 5 days a week.
9. Willing and able to follow instructions and maintain the appointment schedule.

Exclusion Criteria:

1. Anterior segment infection, inflammation or abnormality that would contraindicate contact lens wear.
2. Any active anterior segment ocular disease that would contraindicate contact lens wear.
3. The use of systemic or ocular medications that would contraindicate contact lens wear.
4. History of herpetic keratitis.
5. History of refractive surgery or irregular cornea.
6. Slit lamp findings that are more serious than grade 1 (see ISO 11980 scale).
7. Inactive (i.e. ghost) vessels greater than 1 mm of penetration into the cornea.
8. Participation of the participant in a contact lens or contact lens care product clinical trial within the previous 90 days if involving orthokeratology, 30 days if involving extended wear, rigid gas permeable corneal and scleral lenses, or 15 days if involving daily disposable, daily wear soft lenses.

Where it's running

  • Drs. Mcintyre Garza Avila & Jurica
    Corpus Christi, Texas, United States
    Recruiting
  • Sacco Eye Group
    New York, New York, United States
    Not yet recruiting
  • ProCare Vision Center
    Granville, Ohio, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.